BECTON, DICKINSON AND COMPANY (BDX) Current Ratio
- Current ratio · latest quarter: Value 0.87×; Formula and calculation Current assets / current liabilities..
Current ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Current ratio · latest quarter | 0.87× | Current assets / current liabilities. $8.14B ÷ $9.40B ≈ 0.87× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current assets | 8.14B USD | Assets, Current |
| Current obligations | 9.40B USD | Liabilities, Current |
| Cash and equivalents | 708.00M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | 2.36B USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory | 3.32B USD | Inventory, Net |
| Payables | (m) | Accounts Payable, Current |
| Borrowing debt due within one year | (m) | Long-term Debt, Current Maturities |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current assets (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory (USD) | Payables (USD) | Borrowing debt due within one year (USD) | Current ratio |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $8.14B | $9.40B | $708.00M | (m) | $2.36B | $3.32B | (m) | (m) | 0.87× |
| 2026-03-31 | $8.01B | $8.51B | $813.00M | (m) | $2.21B | $3.36B | (m) | (m) | 0.94× |
| 2025-12-31 | $9.19B | $8.76B | $740.00M | (m) | $2.51B | $4.08B | (m) | (m) | 1.05× |
| 2025-09-30 | $9.26B | $8.31B | $567.00M | (m) | $2.40B | $3.15B | (m) | (m) | 1.11× |
| 2025-06-30 | $9.00B | $8.16B | $735.00M | (m) | $2.94B | $3.95B | (m) | (m) | 1.10× |
| 2025-03-31 | $8.67B | $7.69B | $667.00M | (m) | $3.03B | $3.72B | (m) | (m) | 1.13× |
| 2024-12-31 | $8.66B | $7.66B | $711.00M | (m) | $2.64B | $3.86B | (m) | (m) | 1.13× |
| 2024-09-30 | $10.47B | $8.96B | $1.72B | (m) | $3.03B | $3.84B | $1.90B | (m) | 1.17× |
| 2024-06-30 | $12.21B | $6.61B | $4.46B | (m) | $2.60B | $3.25B | (m) | (m) | 1.85× |
| 2024-03-31 | $10.34B | $7.33B | $2.35B | (m) | $2.56B | $3.23B | (m) | (m) | 1.41× |
| 2023-12-31 | $8.16B | $7.54B | $1.18B | (m) | $2.27B | $3.30B | (m) | (m) | 1.08× |
| 2023-09-30 | $8.68B | $6.64B | $1.42B | (m) | $2.53B | $3.27B | $1.64B | (m) | 1.31× |
| 2023-06-30 | $8.59B | $6.88B | $923.00M | (m) | $2.41B | $3.59B | (m) | (m) | 1.25× |
| 2023-03-31 | $9.59B | $7.30B | $1.98B | (m) | $2.41B | $3.66B | (m) | (m) | 1.31× |
| 2022-12-31 | $8.18B | $7.63B | $612.00M | (m) | $2.28B | $3.60B | (m) | (m) | 1.07× |
| 2022-09-30 | $8.14B | $7.81B | $1.01B | (m) | $2.19B | $3.22B | $1.70B | (m) | 1.04× |
| 2022-06-30 | $9.55B | $7.08B | $2.56B | (m) | $2.22B | $3.16B | (m) | (m) | 1.35× |
| 2022-03-31 | $10.15B | $6.66B | $3.15B | (m) | $2.30B | $3.26B | (m) | (m) | 1.53× |
| 2021-12-31 | $8.31B | $6.74B | $1.90B | (m) | $2.18B | $3.04B | (m) | (m) | 1.23× |
| 2021-09-30 | $8.84B | $6.63B | $2.28B | (m) | $2.35B | $2.74B | $1.74B | (m) | 1.33× |
| 2021-06-30 | $9.54B | $7.75B | $3.15B | (m) | $2.08B | $2.95B | (m) | (m) | 1.23× |
| 2021-03-31 | $10.00B | $5.38B | $3.73B | (m) | $2.12B | $2.90B | (m) | (m) | 1.86× |
| 2020-12-31 | $9.54B | $7.02B | $3.25B | (m) | $2.37B | $2.81B | (m) | (m) | 1.36× |
| 2020-09-30 | $8.97B | $5.84B | $2.83B | (m) | $2.40B | $2.74B | $1.35B | (m) | 1.54× |
| 2020-06-30 | $8.83B | $6.07B | $2.88B | (m) | $1.99B | $2.94B | (m) | (m) | 1.45× |
| 2020-03-31 | $8.55B | $8.76B | $2.35B | (m) | $2.16B | $2.79B | (m) | (m) | 0.98× |
| 2019-12-31 | $6.44B | $6.73B | $560.00M | (m) | $2.07B | $2.76B | (m) | (m) | 0.96× |
| 2019-09-30 | $6.66B | $5.66B | $536.00M | (m) | $2.35B | $2.58B | $1.09B | (m) | 1.18× |
| 2019-06-30 | $6.78B | $6.24B | $523.00M | (m) | $2.22B | $2.63B | (m) | (m) | 1.09× |
| 2019-03-31 | $6.84B | $7.11B | $686.00M | (m) | $2.28B | $2.63B | (m) | (m) | 0.96× |
| 2018-12-31 | $6.94B | $7.14B | $943.00M | (m) | $2.22B | $2.52B | (m) | (m) | 0.97× |
| 2018-09-30 | $7.41B | $7.22B | $1.14B | (m) | $2.32B | $2.45B | $1.11B | (m) | 1.03× |
| 2018-06-30 | $7.53B | $6.11B | $1.38B | (m) | $2.24B | $2.56B | (m) | (m) | 1.23× |
| 2018-03-31 | $7.51B | $4.43B | $1.25B | (m) | $2.29B | $2.54B | (m) | (m) | 1.70× |
| 2017-12-31 | $7.54B | $4.89B | $1.12B | (m) | $2.00B | $2.97B | (m) | (m) | 1.54× |
| 2017-09-30 | $18.63B | $3.34B | $14.18B | (m) | $1.74B | $1.82B | $797.00M | (m) | 5.58× |
| 2017-06-30 | $18.21B | $3.27B | $13.85B | (m) | $1.75B | $1.83B | (m) | (m) | 5.56× |
| 2017-03-31 | $4.89B | $4.02B | $548.00M | (m) | $1.57B | $1.75B | (m) | (m) | 1.22× |
| 2016-12-31 | $5.19B | $4.57B | $919.00M | (m) | $1.52B | $1.69B | (m) | (m) | 1.14× |
| 2016-09-30 | $6.37B | $4.40B | $1.54B | (m) | $1.62B | $1.72B | $665.00M | (m) | 1.45× |
| 2016-06-30 | $6.53B | $4.22B | $1.69B | (m) | $1.62B | $1.83B | (m) | (m) | 1.55× |
| 2016-03-31 | $6.61B | $4.38B | $1.70B | (m) | (m) | $1.85B | (m) | (m) | 1.51× |
| 2015-12-31 | $5.64B | $4.53B | $1.58B | (m) | (m) | $1.99B | (m) | (m) | 1.25× |
| 2015-09-30 | $5.66B | $4.38B | $1.42B | (m) | $1.62B | $1.96B | $631.00M | (m) | 1.29× |
| 2015-06-30 | $6.30B | $4.52B | $1.56B | (m) | (m) | $2.02B | (m) | (m) | 1.40× |
| 2015-03-31 | $7.00B | $4.50B | $1.91B | (m) | (m) | $2.28B | (m) | (m) | 1.56× |
| 2014-12-31 | $12.11B | $2.08B | $8.54B | (m) | (m) | $1.51B | (m) | (m) | 5.82× |
| 2014-09-30 | $6.13B | $2.23B | $1.86B | (m) | (m) | $1.50B | $401.00M | $0.00 | 2.74× |
| 2014-06-30 | $6.04B | $2.09B | $1.66B | (m) | (m) | $1.55B | (m) | (m) | 2.89× |
| 2014-03-31 | $5.95B | $2.02B | $1.73B | (m) | (m) | $1.51B | (m) | (m) | 2.95× |
| 2013-12-31 | $5.74B | $2.00B | $1.68B | (m) | (m) | $1.47B | (m) | (m) | 2.88× |
| 2013-09-30 | $5.87B | $2.13B | $1.89B | (m) | (m) | $1.40B | $333.00M | (m) | 2.76× |
| 2013-06-30 | $5.43B | $1.69B | $1.96B | (m) | (m) | $1.41B | (m) | (m) | 3.21× |
| 2013-03-31 | $5.50B | $1.88B | $2.02B | (m) | (m) | $1.39B | (m) | (m) | 2.93× |
| 2012-12-31 | $5.48B | $2.00B | $1.92B | (m) | (m) | $1.36B | (m) | (m) | 2.73× |
| 2012-09-30 | $5.32B | $1.98B | $1.67B | (m) | (m) | $1.24B | $350.00M | $202.00M | 2.69× |
| 2012-06-30 | $5.28B | $1.89B | $1.66B | (m) | (m) | $1.24B | (m) | (m) | 2.80× |
| 2012-03-31 | $5.30B | $1.62B | $1.84B | (m) | (m) | $1.32B | (m) | (m) | 3.27× |
| 2011-12-31 | $5.69B | $1.61B | $2.20B | (m) | (m) | $1.26B | (m) | (m) | 3.54× |
| 2011-09-30 | $4.67B | $1.82B | $1.18B | (m) | (m) | $1.24B | $304.84M | $22.00K | 2.56× |
| 2011-06-30 | $5.07B | $1.66B | $1.16B | (m) | (m) | $1.33B | (m) | (m) | 3.06× |
| 2011-03-31 | $4.86B | $1.58B | $748.59M | (m) | (m) | $1.28B | (m) | (m) | 3.08× |
| 2010-12-31 | $4.95B | $1.61B | $1.25B | (m) | (m) | $1.20B | (m) | (m) | 3.07× |
| 2010-09-30 | $4.51B | $1.67B | $1.22B | (m) | (m) | $1.15B | $325.40M | $31.00K | 2.70× |
| 2010-06-30 | $4.12B | $1.53B | $750.11M | (m) | (m) | $1.12B | (m) | (m) | 2.69× |
| 2010-03-31 | $3.94B | $1.47B | $830.69M | (m) | (m) | $1.17B | (m) | (m) | 2.68× |
| 2009-12-31 | $4.06B | $1.54B | $1.18B | (m) | (m) | $1.16B | (m) | (m) | 2.64× |
| 2009-09-30 | $4.65B | $1.78B | $1.39B | (m) | (m) | $1.16B | $264.18M | $200.09M | 2.61× |
| 2009-06-30 | $4.49B | $1.65B | $1.33B | (m) | (m) | $1.21B | (m) | (m) | 2.73× |
| 2008-09-30 | $3.61B | $1.42B | $830.48M | (m) | (m) | $1.08B | $260.88M | (m) | 2.55× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| BOSTON SCIENTIFIC CORP (BSX) | United States | $64.781B | 17.29 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |